SpaceOAR Post-Market Registry Study

Inclusion Criteria

• •All patients with a clinical diagnosis of prostate cancer planned to undergo treatment with curative intent at selected sites in the UK \& France subject to a SpaceOAR being used as usual care.
• •Aged 18 years old or above.
• •Patients who agrees to participate and has been deemed by their medical team to have capacity to provide;
• •* verbal, informed consent over telephone as documented on the study informed consent form by the Researchers (UK only)
• •* written, informed consent by signature of the study informed consent form (France only)
• •Patient covered by social security scheme (France only)